22.86
Tandem Diabetes Care Inc (TNDM) 最新ニュース
Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set - MassDevice
Tandem Diabetes Care gets FDA clearance for new set By Investing.com - Investing.com Nigeria
Tandem Diabetes Care gets FDA clearance for new set - Investing.com
Tandem's Initial Growth Spurt From the Launch of Mobi Should Moderate in the Near Term - Morningstar
Investor Network: Tandem Diabetes Care, Inc. to Host Earnings Call - ACCESS Newswire
INVESTOR ALERT: Levi & Korsinsky Notifies Tandem Diabetes Care, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – TNDM - ACCESS Newswire
INVESTOR ALERT: Levi & Korsinsky Notifies Tandem Diabetes Care, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineTNDM - ACCESS Newswire
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Tandem Diabetes Care, Inc.(TNDM) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
INVESTOR ALERT: Levi & Korsinsky Reminds Tandem Diabetes Care, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2023TNDM - ACCESS Newswire
INVESTOR ALERT: Levi & Korsinsky Reminds Tandem Diabetes Care, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2023 – TNDM - ACCESS Newswire
Diabetes segment reports good news all around - BioWorld MedTech
Tandem Diabetes Care Announces Upcoming Conference Presentations - BioSpace
BlackRock, Inc. Reduces Stake in Tandem Diabetes Care Inc - GuruFocus
Insulin Pump Market Poised for 8.3% CAGR Growth Through 2033 - openPR.com
Earnings Release: Here's Why Analysts Cut Their Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Price Target To US$35.52 - simplywall.st
Tandem Diabetes jumps as overseas sales drive Q1 beat - MSN
Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates - MSN
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2025 Earnings Call Transcript - Insider Monkey
TNDM Stock Rises Despite Q1 Earnings Miss, Gross Margin Up - Yahoo Finance
Tandem Diabetes Care First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Tandem Diabetes Care (TNDM): Analyst Maintains "Buy" Rating and Raises Target Price | TNDM Stock News - GuruFocus
Tandem Diabetes (TNDM) Shares Surge on Robust Q1 Revenue - GuruFocus
Tandem Diabetes Care Reports Record Sales and Strategic Growth - TipRanks
Tandem Diabetes stock jumps on Q1 results (TNDM:NASDAQ) - Seeking Alpha
Tandem Diabetes Care (TNDM) Target Price Lowered by Wells Fargo - GuruFocus
TNDM: Stifel Adjusts Price Target for Tandem Diabetes Care | TND - GuruFocus
TNDM: Piper Sandler Adjusts Price Target Amid Overweight Rating - GuruFocus
TNDM: Baird Maintains Neutral Rating, Lowers Price Target | TNDM Stock News - GuruFocus
Canaccord raises Tandem Diabetes Care target to $59 - Investing.com
Tandem Diabetes Care Stock: A Deep Dive Into Analyst Perspectives (10 Ratings) - Benzinga
Tandem Diabetes (TNDM) Sees Price Target Reduced by Baird | TNDM Stock News - GuruFocus
Tandem Diabetes (TNDM) Price Target Raised by Canaccord Amid Pro - GuruFocus
Tandem Diabetes (TNDM) Target Price Revised as Analysts Remain O - GuruFocus
Tandem Diabetes (TNDM) Price Target Adjusted by Analyst | TNDM S - GuruFocus
Tandem Diabetes Care Inc (TNDM) Q1 2025 Earnings: Revenue Surpas - GuruFocus
Tandem Diabetes Care Inc (TNDM) Q1 2025 Earnings Call Highlights: Record Sales and Strategic ... - Yahoo Finance
Tandem Diabetes Care Reports 22.3% Revenue Increase in Q1 CY2025News and Statistics - IndexBox
Tandem Diabetes Care Inc (TNDM) Q1 2025 Earnings Call Highlights - GuruFocus
Tandem's (TNDM) Strong Q1 Revenue Surpasses Expectations | TNDM Stock News - GuruFocus
Tandem Diabetes Care (TNDM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Tandem Diabetes Care Announces First Quarter 2025 Financial Results - BioSpace
Earnings call transcript: Tandem Diabetes Care Q1 2025 Misses EPS, Stock Rises - Investing.com
Tandem Diabetes’s (NASDAQ:TNDM) Q1: Beats On Revenue, Stock Soars - Yahoo Finance
Tandem Diabetes Q1 2025 slides: dual-platform strategy targets underpenetrated market - Investing.com
Tandem Diabetes (NASDAQ:TNDM) Posts Better-Than-Expected Sales In Q1, Stock Soars - Yahoo Finance
Tandem Diabetes stock surges on revenue beat, strong guidance By Investing.com - Investing.com Nigeria
大文字化:
|
ボリューム (24 時間):